0

EN ISO 16256:2012

Clinical laboratory testing and in vitro diagnostic test systems - Reference method for testing the in vitro activity of antimicrobial agents against yeast of fungi involved in infectious diseases (ISO 16256:2012) EN ISO 16256:2012

Publication date:   Jan 22, 2013

General information

99.60 Withdrawal effective   Oct 27, 2021

CEN

CEN/TC 140 In vitro diagnostic medical devices

European Norm

11.100.10   In vitro diagnostic test systems

Buying

Withdrawn

Language in which you want to receive the document.

Scope

ISO 16256:2012 describes a method for testing the susceptibility to antifungal agents of yeasts, including Candida spp. and Cryptococcus neoformans, that cause infections. The reference method described here has not been used in studies of the yeast forms of dimorphic fungi, such as B. dermatitidis and/or H. capsulatum variety capsulatum.
ISO 16256:2012 describes the broth microdilution reference method which can be implemented by either of two pathways. One pathway involves visual determination of MICs (CLSI method); the second pathway involves spectrophotometric determination of MICs (EUCAST method).

Life cycle

NOW

WITHDRAWN
EN ISO 16256:2012
99.60 Withdrawal effective
Oct 27, 2021

REVISED BY

PUBLISHED
EN ISO 16256:2021